Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease-Reference-Cited by-同舟云学术

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Published:2015-05-29 Issue:3 Volume:278 Page:323-332
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Brauner S.¹,Zhou W.¹,Backlin C.²,Green T. M.³⁴,Folkersen L.¹,Ivanchenko M.¹,Löfström B.⁵,Xu-Monette Z. Y.⁶,Young K. H.⁶,Møller Pedersen L.⁴,Boe Møller M.³⁴,Sundström C.⁷,Enblad G.⁸,Baecklund E.²,Wahren-Herlenius M.¹

Affiliation:

1. Unit of Experimental Rheumatology; Department of Medicine; Karolinska University Hospital; Karolinska Institutet; Stockholm Sweden

2. Unit of Rheumatology; Department of Medical Sciences; Uppsala University; Uppsala Sweden

3. Institute of Clinical Research; University of Southern Denmark; Odense Denmark

4. Odense University Hospital; Odense Denmark

5. Rheumatology Clinic; Malar Hospital; Eskilstuna Sweden

6. Department of Hematopathology; University of Texas; MD Anderson Cancer Center; Houston TX USA

7. Department of Immunology, Genetics and Pathology; Rudbeck Laboratory; Uppsala University; Uppsala Sweden

8. Unit of Oncology; Department of Radiology, Oncology and Radiation Sciences; Uppsala University; Uppsala Sweden

Funder

Swedish Research Council

Heart-Lung Foundation

Stockholm County Council

Karolinska Institutet

Swedish Rheumatism Association

King Gustaf Vth 80-year Foundation

Torsten and Ragnar Söderberg Foundation

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12375/fullpdf

Reference36 articles.

1. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma;Fu;J Clin Oncol,2008

2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

3. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

4. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis;Berglund;Mod Pathol,2005

5. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma;Dias;Nat Rev Rheumatol,2011

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of TRIM21/Ro52 in connective tissue disease-associated interstitial lung diseases;Frontiers in Immunology;2024-08-06

2. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren’s Patients Reveals Interferon Signature;Genes;2024-05-15

3. MiR-99a-3p downregulates TRIM21 to promote gastric cancer development;Molecular and Cellular Biochemistry;2024-05-08

4. The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis;Journal of Experimental & Clinical Cancer Research;2024-05-04

5. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway;Cancer Science;2024-03-12